Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate-pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy.
about
Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate-pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Sex differences in the pharmac ...... pharmacotherapy in pregnancy.
@en
Sex differences in the pharmac ...... pharmacotherapy in pregnancy.
@nl
type
label
Sex differences in the pharmac ...... pharmacotherapy in pregnancy.
@en
Sex differences in the pharmac ...... pharmacotherapy in pregnancy.
@nl
prefLabel
Sex differences in the pharmac ...... pharmacotherapy in pregnancy.
@en
Sex differences in the pharmac ...... pharmacotherapy in pregnancy.
@nl
P2093
P2860
P356
P1476
Sex differences in the pharmac ...... pharmacotherapy in pregnancy.
@en
P2093
Manon Vranderick
Simerpal K Gill
Stuart Macleod
P2860
P304
P356
10.1002/JCPH.184
P50
P577
2013-10-10T00:00:00Z